Melissa officinalis Protects against Doxorubicin-Induced Cardiotoxicity in Rats and Potentiates Its Anticancer Activity on MCF-7 Cells

Cardiotoxicity is a limiting factor of doxorubicin (DOX)-based anticancer therapy. Due to its beneficial effects, we investigated whether standardized extract of Melissa officinalis (MO) can attenuate doxorubicin-induced cardiotoxicity and can potentiate the efficacy of DOX against human breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamza, Alaaeldin Ahmed, Ahmed, Mahguob Mohamed, Elwey, Hanan Mohamed, Amin, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120835/
https://www.ncbi.nlm.nih.gov/pubmed/27880817
http://dx.doi.org/10.1371/journal.pone.0167049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120835/
https://www.ncbi.nlm.nih.gov/pubmed/27880817
http://dx.doi.org/10.1371/journal.pone.0167049

Ejemplares similares